Clinical Trial Update: The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of Huaiqihuang Granule in children with chronic primary immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Huaiqihuang Granule

Snippet

Sponsor: Qidong Gaitianli Medicines Co., Ltd | Conditions: Immune Thrombocytopenia | Phase 4 | Status: ACTIVE_NOT_RECRUITING